Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
ABC transporters and multidrug resistance [[electronic resource] /] / edited by Ahcène Boumendjel, Jean Boutonnat, Jacques Robert
| ABC transporters and multidrug resistance [[electronic resource] /] / edited by Ahcène Boumendjel, Jean Boutonnat, Jacques Robert |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley & Sons, c2009 |
| Descrizione fisica | 1 online resource (475 p.) |
| Disciplina |
572/.696
615.1 |
| Altri autori (Persone) |
BoumendjelAhcène
BoutonnatJean RobertJacques, M.D. |
| Collana | Wiley series in drug discovery and development |
| Soggetto topico |
ATP-binding cassette transporters
Drug resistance in cancer cells |
| ISBN |
1-282-36879-6
9786612368790 0-470-49513-8 0-470-49512-X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ABC TRANSPORTERS AND MULTIDRUG RESISTANCE; CONTENTS; PREFACE; CONTRIBUTORS; INTRODUCTION: WHAT IS MULTIDRUG RESISTANCE?; PART I ABC PROTEINS: AN OVERVIEW AND DESCRIPTION OF THE STRUCTURE, GENOME, NORMAL TISSUE EXPRESSION, PHYSIOLOGICAL ASPECT, AND MECHANISM OF ACTION; 1 The P-glycoprotein 170: Just a multidrug resistance protein or a protean molecule?; 2 Multidrug resistance-associated protein (MRP/ABCC proteins); 3 ABCG2: A new challenge in cancer drug resistance
PART II ABC PROTEINS AND ONCOLOGY: EXPRESSION, DETECTION, AND IMPLICATION OF ABC PROTEINS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS4 Expression, detection, and implication of ABC proteins in acute myeloblastic leukemia; 5 ABC proteins and oncology: Expression, detection, and implication of ABC proteins in solid tumors; PART III ABC PROTEINS AND PATHOGENIC MICROORGANISMS; 6 ABC transporters and resistance to antibiotics; 7 ABC proteins involved in protozoan parasite resistance PART IV MULTIDRUG RESISTANCE (MDR) MODULATION THROUGH INHIBITION OF ABC TRANSPORTERS: DESIGN OF INHIBITORS AND MECHANISM OF ACTION8 Reversal agents for P-glycoprotein-mediated multidrug resistance; 9 Reversal agents of multidrug resistance mediated by multidrug resistance-associated proteins (MRPs); 10 Reversal agents for breast cancer resistance protein (BCRP)-mediated multidrug resistance; 11 Strategies to overcome drug resistance in acute and chronic leukemias; 12 Multidrug resistance reversal in solid tumors PART V BIOLOGICAL AND CLINICAL ASPECTS OF MULTIDRUG RESISTANCE: THE ROLE OF THE TRANSPORTERS AT THE MAIN PROTECTION BARRIERS (ABCB1, ABCC1, ABCC2, ABCG2) ON THE BIOAVAILABILITY OF MANY TYPES OF DRUGS AND MEDICATIONS13 ABC superfamily transporters at the human blood-brain barrier; 14 The role of ABC transporters at the intestinal barrier; 15 Genetic polymorphisms in ABC transporters; PERSPECTIVES; INDEX |
| Record Nr. | UNINA-9910139988203321 |
| Hoboken, NJ, : John Wiley & Sons, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
ABC transporters and multidrug resistance [[electronic resource] /] / edited by Ahcène Boumendjel, Jean Boutonnat, Jacques Robert
| ABC transporters and multidrug resistance [[electronic resource] /] / edited by Ahcène Boumendjel, Jean Boutonnat, Jacques Robert |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley & Sons, c2009 |
| Descrizione fisica | 1 online resource (475 p.) |
| Disciplina |
572/.696
615.1 |
| Altri autori (Persone) |
BoumendjelAhcène
BoutonnatJean RobertJacques, M.D. |
| Collana | Wiley series in drug discovery and development |
| Soggetto topico |
ATP-binding cassette transporters
Drug resistance in cancer cells |
| ISBN |
1-282-36879-6
9786612368790 0-470-49513-8 0-470-49512-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ABC TRANSPORTERS AND MULTIDRUG RESISTANCE; CONTENTS; PREFACE; CONTRIBUTORS; INTRODUCTION: WHAT IS MULTIDRUG RESISTANCE?; PART I ABC PROTEINS: AN OVERVIEW AND DESCRIPTION OF THE STRUCTURE, GENOME, NORMAL TISSUE EXPRESSION, PHYSIOLOGICAL ASPECT, AND MECHANISM OF ACTION; 1 The P-glycoprotein 170: Just a multidrug resistance protein or a protean molecule?; 2 Multidrug resistance-associated protein (MRP/ABCC proteins); 3 ABCG2: A new challenge in cancer drug resistance
PART II ABC PROTEINS AND ONCOLOGY: EXPRESSION, DETECTION, AND IMPLICATION OF ABC PROTEINS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS4 Expression, detection, and implication of ABC proteins in acute myeloblastic leukemia; 5 ABC proteins and oncology: Expression, detection, and implication of ABC proteins in solid tumors; PART III ABC PROTEINS AND PATHOGENIC MICROORGANISMS; 6 ABC transporters and resistance to antibiotics; 7 ABC proteins involved in protozoan parasite resistance PART IV MULTIDRUG RESISTANCE (MDR) MODULATION THROUGH INHIBITION OF ABC TRANSPORTERS: DESIGN OF INHIBITORS AND MECHANISM OF ACTION8 Reversal agents for P-glycoprotein-mediated multidrug resistance; 9 Reversal agents of multidrug resistance mediated by multidrug resistance-associated proteins (MRPs); 10 Reversal agents for breast cancer resistance protein (BCRP)-mediated multidrug resistance; 11 Strategies to overcome drug resistance in acute and chronic leukemias; 12 Multidrug resistance reversal in solid tumors PART V BIOLOGICAL AND CLINICAL ASPECTS OF MULTIDRUG RESISTANCE: THE ROLE OF THE TRANSPORTERS AT THE MAIN PROTECTION BARRIERS (ABCB1, ABCC1, ABCC2, ABCG2) ON THE BIOAVAILABILITY OF MANY TYPES OF DRUGS AND MEDICATIONS13 ABC superfamily transporters at the human blood-brain barrier; 14 The role of ABC transporters at the intestinal barrier; 15 Genetic polymorphisms in ABC transporters; PERSPECTIVES; INDEX |
| Record Nr. | UNINA-9910830388703321 |
| Hoboken, NJ, : John Wiley & Sons, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
ABC transporters and multidrug resistance [[electronic resource] /] / edited by Ahcène Boumendjel, Jean Boutonnat, Jacques Robert
| ABC transporters and multidrug resistance [[electronic resource] /] / edited by Ahcène Boumendjel, Jean Boutonnat, Jacques Robert |
| Pubbl/distr/stampa | Hoboken, NJ, : John Wiley & Sons, c2009 |
| Descrizione fisica | 1 online resource (475 p.) |
| Disciplina |
572/.696
615.1 |
| Altri autori (Persone) |
BoumendjelAhcène
BoutonnatJean RobertJacques, M.D. |
| Collana | Wiley series in drug discovery and development |
| Soggetto topico |
ATP-binding cassette transporters
Drug resistance in cancer cells |
| ISBN |
1-282-36879-6
9786612368790 0-470-49513-8 0-470-49512-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ABC TRANSPORTERS AND MULTIDRUG RESISTANCE; CONTENTS; PREFACE; CONTRIBUTORS; INTRODUCTION: WHAT IS MULTIDRUG RESISTANCE?; PART I ABC PROTEINS: AN OVERVIEW AND DESCRIPTION OF THE STRUCTURE, GENOME, NORMAL TISSUE EXPRESSION, PHYSIOLOGICAL ASPECT, AND MECHANISM OF ACTION; 1 The P-glycoprotein 170: Just a multidrug resistance protein or a protean molecule?; 2 Multidrug resistance-associated protein (MRP/ABCC proteins); 3 ABCG2: A new challenge in cancer drug resistance
PART II ABC PROTEINS AND ONCOLOGY: EXPRESSION, DETECTION, AND IMPLICATION OF ABC PROTEINS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS4 Expression, detection, and implication of ABC proteins in acute myeloblastic leukemia; 5 ABC proteins and oncology: Expression, detection, and implication of ABC proteins in solid tumors; PART III ABC PROTEINS AND PATHOGENIC MICROORGANISMS; 6 ABC transporters and resistance to antibiotics; 7 ABC proteins involved in protozoan parasite resistance PART IV MULTIDRUG RESISTANCE (MDR) MODULATION THROUGH INHIBITION OF ABC TRANSPORTERS: DESIGN OF INHIBITORS AND MECHANISM OF ACTION8 Reversal agents for P-glycoprotein-mediated multidrug resistance; 9 Reversal agents of multidrug resistance mediated by multidrug resistance-associated proteins (MRPs); 10 Reversal agents for breast cancer resistance protein (BCRP)-mediated multidrug resistance; 11 Strategies to overcome drug resistance in acute and chronic leukemias; 12 Multidrug resistance reversal in solid tumors PART V BIOLOGICAL AND CLINICAL ASPECTS OF MULTIDRUG RESISTANCE: THE ROLE OF THE TRANSPORTERS AT THE MAIN PROTECTION BARRIERS (ABCB1, ABCC1, ABCC2, ABCG2) ON THE BIOAVAILABILITY OF MANY TYPES OF DRUGS AND MEDICATIONS13 ABC superfamily transporters at the human blood-brain barrier; 14 The role of ABC transporters at the intestinal barrier; 15 Genetic polymorphisms in ABC transporters; PERSPECTIVES; INDEX |
| Record Nr. | UNINA-9910840786103321 |
| Hoboken, NJ, : John Wiley & Sons, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in cancer research . Volume 125 ABC transporters and cancer / / edited by John D. Schuetz, Toshihisa Ishikawa ; contributors Suresh V. Ambudkar [and thirty one others]
| Advances in cancer research . Volume 125 ABC transporters and cancer / / edited by John D. Schuetz, Toshihisa Ishikawa ; contributors Suresh V. Ambudkar [and thirty one others] |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (280 p.) |
| Disciplina | 616.9940072 |
| Soggetto topico |
Cancer - Research
Drug resistance in cancer cells Cancer - Chemotherapy |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-12-801361-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; ABC Transporters and Cancer; Copyright; Dedication; Contents; Contributors; Preface; Chapter 1: Apical ABC Transporters and Cancer Chemotherapeutic Drug Disposition; 1. Introduction to Apical ABC Transporters; 2. Impact of Apical ABC Transporters on Intestinal Absorption of Oral Chemotherapeutic Drugs; 2.1. Apical ABC transporters affecting the oral bioavailability of taxanes; 2.1.1. ABCB1 and oral taxane availability; 2.1.2. ABCC2 and oral taxane availability; 2.1.3. ABCB1 inhibitors to improve taxane oral availability
2.1.4. Assessing CNS toxicity risks of using ABCB1 inhibitors to improve oral taxane availability2.1.5. Possible effects of ABCB1 inhibitors on enhancing taxane antitumor efficacy; 2.2. Apical ABC transporters in the oral bioavailability of rationally designed anticancer drugs; 2.2.1. Tyrosine kinase inhibitors; 2.2.2. PARP inhibitors; 2.2.3. Chemical inhibition of transporters to increase oral availability of rationally designed anticancer drugs; 2.2.4. Importance of the sensitivity and specificity of in vitro assays used to assess ABC transporter substrates 3. Impact of Apical ABC Transporters on Brain Disposition of Oral Chemotherapeutic Drugs3.1. Does the BBB matter in drug delivery to brain tumors?; 3.2. Apical efflux transporters in the BBB affecting brain accumulation of anticancer drugs; 3.2.1. Drugs affected mostly by Abcb1a but also by Abcg2 in their brain accumulation; 3.2.2. Drugs only affected by Abcb1a in their brain accumulation; 3.2.3. Drugs affected mostly by Abcg2 but also by Abcb1a in their brain accumulation; 3.2.4. Three different apical BBB ABC efflux transporters affect brain accumulation of some camptothecins 3.2.5. Models to explain the disproportionate effect of combined deficiency of Abcb1 and Abcg2 on brain accumulation of s...3.2.6. Why are many rationally designed anticancer drugs still ABCB1 and/or ABCG2 substrates?; 3.2.7. Limitations of knockout mouse models to study ABC transporter functions at the BBB; 3.2.8. Tissue and cellular context may affect the in vivo impact of apical ABC efflux transporters; 3.2.9. Use of chemical inhibitors to enhance brain accumulation of ABC transporter substrate drugs; 4. Concluding Remarks; References Chapter 2: Regulation of ABC Transporters Blood-Brain Barrier: The Good, the Bad, and the Ugly1. Introduction; 2. Blood-Brain Barriers; 2.1. Assessing blood-brain barrier function; 3. ABC Transporters at the Blood-Brain Barrier; 4. The Bad and the Ugly: Mechanisms that Increase Transporter Expression and Reduce Drug Delivery to the CNS; 4.1. Xenobiotic-activated transcription factors; 4.2. Stress-activated transcription factors; 4.3. Disease; 5. The Good: Mechanisms that Reduce Transporter Activity/Expression and Have the Potential to Improve Drug Delivery to th...; 5.1. P-glycoprotein 5.2. BCRP |
| Record Nr. | UNINA-9910460672103321 |
| London, England : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in cancer research . Volume 125 ABC transporters and cancer / / edited by John D. Schuetz, Toshihisa Ishikawa ; contributors Suresh V. Ambudkar [and thirty one others]
| Advances in cancer research . Volume 125 ABC transporters and cancer / / edited by John D. Schuetz, Toshihisa Ishikawa ; contributors Suresh V. Ambudkar [and thirty one others] |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (280 p.) |
| Disciplina | 616.9940072 |
| Soggetto topico |
Cancer - Research
Drug resistance in cancer cells Cancer - Chemotherapy |
| ISBN | 0-12-801361-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; ABC Transporters and Cancer; Copyright; Dedication; Contents; Contributors; Preface; Chapter 1: Apical ABC Transporters and Cancer Chemotherapeutic Drug Disposition; 1. Introduction to Apical ABC Transporters; 2. Impact of Apical ABC Transporters on Intestinal Absorption of Oral Chemotherapeutic Drugs; 2.1. Apical ABC transporters affecting the oral bioavailability of taxanes; 2.1.1. ABCB1 and oral taxane availability; 2.1.2. ABCC2 and oral taxane availability; 2.1.3. ABCB1 inhibitors to improve taxane oral availability
2.1.4. Assessing CNS toxicity risks of using ABCB1 inhibitors to improve oral taxane availability2.1.5. Possible effects of ABCB1 inhibitors on enhancing taxane antitumor efficacy; 2.2. Apical ABC transporters in the oral bioavailability of rationally designed anticancer drugs; 2.2.1. Tyrosine kinase inhibitors; 2.2.2. PARP inhibitors; 2.2.3. Chemical inhibition of transporters to increase oral availability of rationally designed anticancer drugs; 2.2.4. Importance of the sensitivity and specificity of in vitro assays used to assess ABC transporter substrates 3. Impact of Apical ABC Transporters on Brain Disposition of Oral Chemotherapeutic Drugs3.1. Does the BBB matter in drug delivery to brain tumors?; 3.2. Apical efflux transporters in the BBB affecting brain accumulation of anticancer drugs; 3.2.1. Drugs affected mostly by Abcb1a but also by Abcg2 in their brain accumulation; 3.2.2. Drugs only affected by Abcb1a in their brain accumulation; 3.2.3. Drugs affected mostly by Abcg2 but also by Abcb1a in their brain accumulation; 3.2.4. Three different apical BBB ABC efflux transporters affect brain accumulation of some camptothecins 3.2.5. Models to explain the disproportionate effect of combined deficiency of Abcb1 and Abcg2 on brain accumulation of s...3.2.6. Why are many rationally designed anticancer drugs still ABCB1 and/or ABCG2 substrates?; 3.2.7. Limitations of knockout mouse models to study ABC transporter functions at the BBB; 3.2.8. Tissue and cellular context may affect the in vivo impact of apical ABC efflux transporters; 3.2.9. Use of chemical inhibitors to enhance brain accumulation of ABC transporter substrate drugs; 4. Concluding Remarks; References Chapter 2: Regulation of ABC Transporters Blood-Brain Barrier: The Good, the Bad, and the Ugly1. Introduction; 2. Blood-Brain Barriers; 2.1. Assessing blood-brain barrier function; 3. ABC Transporters at the Blood-Brain Barrier; 4. The Bad and the Ugly: Mechanisms that Increase Transporter Expression and Reduce Drug Delivery to the CNS; 4.1. Xenobiotic-activated transcription factors; 4.2. Stress-activated transcription factors; 4.3. Disease; 5. The Good: Mechanisms that Reduce Transporter Activity/Expression and Have the Potential to Improve Drug Delivery to th...; 5.1. P-glycoprotein 5.2. BCRP |
| Record Nr. | UNINA-9910787425603321 |
| London, England : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in cancer research . Volume 125 ABC transporters and cancer / / edited by John D. Schuetz, Toshihisa Ishikawa ; contributors Suresh V. Ambudkar [and thirty one others]
| Advances in cancer research . Volume 125 ABC transporters and cancer / / edited by John D. Schuetz, Toshihisa Ishikawa ; contributors Suresh V. Ambudkar [and thirty one others] |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | London, England : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (280 p.) |
| Disciplina | 616.9940072 |
| Soggetto topico |
Cancer - Research
Drug resistance in cancer cells Cancer - Chemotherapy |
| ISBN | 0-12-801361-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; ABC Transporters and Cancer; Copyright; Dedication; Contents; Contributors; Preface; Chapter 1: Apical ABC Transporters and Cancer Chemotherapeutic Drug Disposition; 1. Introduction to Apical ABC Transporters; 2. Impact of Apical ABC Transporters on Intestinal Absorption of Oral Chemotherapeutic Drugs; 2.1. Apical ABC transporters affecting the oral bioavailability of taxanes; 2.1.1. ABCB1 and oral taxane availability; 2.1.2. ABCC2 and oral taxane availability; 2.1.3. ABCB1 inhibitors to improve taxane oral availability
2.1.4. Assessing CNS toxicity risks of using ABCB1 inhibitors to improve oral taxane availability2.1.5. Possible effects of ABCB1 inhibitors on enhancing taxane antitumor efficacy; 2.2. Apical ABC transporters in the oral bioavailability of rationally designed anticancer drugs; 2.2.1. Tyrosine kinase inhibitors; 2.2.2. PARP inhibitors; 2.2.3. Chemical inhibition of transporters to increase oral availability of rationally designed anticancer drugs; 2.2.4. Importance of the sensitivity and specificity of in vitro assays used to assess ABC transporter substrates 3. Impact of Apical ABC Transporters on Brain Disposition of Oral Chemotherapeutic Drugs3.1. Does the BBB matter in drug delivery to brain tumors?; 3.2. Apical efflux transporters in the BBB affecting brain accumulation of anticancer drugs; 3.2.1. Drugs affected mostly by Abcb1a but also by Abcg2 in their brain accumulation; 3.2.2. Drugs only affected by Abcb1a in their brain accumulation; 3.2.3. Drugs affected mostly by Abcg2 but also by Abcb1a in their brain accumulation; 3.2.4. Three different apical BBB ABC efflux transporters affect brain accumulation of some camptothecins 3.2.5. Models to explain the disproportionate effect of combined deficiency of Abcb1 and Abcg2 on brain accumulation of s...3.2.6. Why are many rationally designed anticancer drugs still ABCB1 and/or ABCG2 substrates?; 3.2.7. Limitations of knockout mouse models to study ABC transporter functions at the BBB; 3.2.8. Tissue and cellular context may affect the in vivo impact of apical ABC efflux transporters; 3.2.9. Use of chemical inhibitors to enhance brain accumulation of ABC transporter substrate drugs; 4. Concluding Remarks; References Chapter 2: Regulation of ABC Transporters Blood-Brain Barrier: The Good, the Bad, and the Ugly1. Introduction; 2. Blood-Brain Barriers; 2.1. Assessing blood-brain barrier function; 3. ABC Transporters at the Blood-Brain Barrier; 4. The Bad and the Ugly: Mechanisms that Increase Transporter Expression and Reduce Drug Delivery to the CNS; 4.1. Xenobiotic-activated transcription factors; 4.2. Stress-activated transcription factors; 4.3. Disease; 5. The Good: Mechanisms that Reduce Transporter Activity/Expression and Have the Potential to Improve Drug Delivery to th...; 5.1. P-glycoprotein 5.2. BCRP |
| Record Nr. | UNINA-9910811415603321 |
| London, England : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Breast cancer metastasis and drug resistance : progress and prospects / / Aamir Ahmad, editor
| Breast cancer metastasis and drug resistance : progress and prospects / / Aamir Ahmad, editor |
| Pubbl/distr/stampa | New York, : Springer, 2013 |
| Descrizione fisica | 1 online resource (415 p.) |
| Disciplina |
616.99/4
616.994 |
| Altri autori (Persone) | AhmadAamir |
| Soggetto topico |
Breast - Cancer
Metastasis Cancer cells Drug resistance in cancer cells |
| ISBN |
1-283-91188-4
1-4614-5647-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- Breast Cancer Statistics -- Epidemiology of Breast Cancer in Women -- The Complexities of Racial Disparity in Breast Cancer -- Major signaling pathways involved in Breast Cancer -- Breast Cancer Heterogeneity in Primary and Metastatic Disease -- Understanding Triple-negative Breast Cancer -- The biology of the deadly love connection between obesity, diabetes and breast cancer -- Progression of Early Breast Cancer to an Invasive Phenotype -- Pre-clinical modeling of breast cancer – which model to choose? -- Modeling breast cancer progression in 4-D -- Bone Metastasis of Breast Cancer -- Cellular and Molecular Mechanisms Involved in Breaching of The Blood-Brian Barrier By Circulating Breast Cancer Cells -- Resistance to Anthracyclines and Taxanes in Breast cancer -- Understanding of Tamoxifen Resistance of Breast Cancer based on Integrative Bioinformatics Approaches -- Current understanding of drug resistance mechanisms and therapeutic targets in HER2 overexpressing breast cancers -- Platinum and ruthenium complexes for the therapy of breast cancer diseases.-Development of Notch Pathway Inhibitors for Cancer Therapy -- Systems Biology Approaches in Breast Cancer Studies -- Epigenetic Factors in Breast Cancer Progression -- Breast Cancer Stem Cells and miRNAs -- Breast Cancer Stem Cells: responsible for therapeutic resistance and relapse? -- MicroRNAs in Breast Cancer Research: Progress and Promise -- Index. |
| Record Nr. | UNINA-9910437835803321 |
| New York, : Springer, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug Repurposing : Molecular Aspects and Therapeutic Applications
| Drug Repurposing : Molecular Aspects and Therapeutic Applications |
| Autore | Saxena Shailendra K |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2022 |
| Descrizione fisica | 1 online resource (386 pages) |
| Disciplina | 615.19 |
| Soggetto topico | Drug resistance in cancer cells |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug Repurposing |
| Record Nr. | UNINA-9910688269403321 |
Saxena Shailendra K
|
||
| London : , : IntechOpen, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug resistance updates
| Drug resistance updates |
| Pubbl/distr/stampa | [London], : Harcourt |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance in microorganisms
Drug resistance in cancer cells Drug resistance Anti-infective agents Drug Resistance Antineoplastic Agents Anti-Infective Agents Communicable Diseases - drug therapy Neoplasms - drug therapy Résistance aux médicaments Micro-organismes - Résistance aux médicaments Cellules cancéreuses - Résistance aux médicaments Anticancéreux Antiinfectieux |
| Soggetto genere / forma |
Periodical
Periodicals. Périodiques. |
| ISSN | 1532-2084 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910333246203321 |
| [London], : Harcourt | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug resistance updates
| Drug resistance updates |
| Pubbl/distr/stampa | [London], : Harcourt |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance in microorganisms
Drug resistance in cancer cells Drug resistance Anti-infective agents Drug Resistance Antineoplastic Agents Anti-Infective Agents Communicable Diseases - drug therapy Neoplasms - drug therapy Résistance aux médicaments Micro-organismes - Résistance aux médicaments Cellules cancéreuses - Résistance aux médicaments Anticancéreux Antiinfectieux |
| Soggetto genere / forma |
Periodical
Periodicals. Périodiques. |
| ISSN | 1532-2084 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996197983603316 |
| [London], : Harcourt | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
